Search Results 3061-3070 of 22499 for oral

1. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

   ... (oral paclitaxel or HM30181A) or pembrolizumab - Currently taking following ... - An oral medication with a narrow therapeutic index known to be a P-gp ...

3. Macroglobulinemia Clinical Trials

   The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...

4. TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study - Mayo Clinic

   ... oral contraceptive. Hormonal contraception must be started at least 1 full cycle prior to Baseline and continue for 180 days after the last dose of ...

5. Poliovirus vaccine, inactivated (injection route) - Mayo Clinic

   The type of vaccine that is given by mouth is called poliovirus vaccine live oral (OPV). Polio is a very serious infection that causes paralysis of the ...

6. Stroke reduction in nonvalvular atrial fibrillation with the left atrial appendage closure device: an update - Mayo Clinic

   ... oral anticoagulation in patients with nonvalvular AF; Suitable for short-term warfarin but deemed unable to take long-term oral anticoagulation. Given this ...

9. Pediatric obstructive sleep apnea - Doctors and departments - Mayo Clinic

   Viozzi, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...

10. Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) - Mayo Clinic

    About this study. Study AG120-C-005 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study of orally administered AG-120.